• Currently, only the manufacturers are held liable under the Drugs and Cosmetics Act
  • Pharmaceutical companies that market drugs will now fall under the ambit of the Drugs and Cosmetics Act (DCA), according to a notification issued by the Ministry of Health and Family Welfare (MoHFW).
  • This means they will be held liable if the drug is found to be spurious, or its quality is deemed sub-standard.
  • At present, only the manufacturer of the drug is held liable under the DCA.
  • The pharma firms themselves, which market the drug, would lend the products their brand names, affixing their names on the packages for sale and distribution..

Read full article: thehindubusinessline.com

Comments are closed.